Bringing International Medtech Innovation to the U.S.
We help emerging medtech, biotech, diagnostics, and healthtech companies expand into the U.S. with precision- guiding regulatory, clinical, reimbursement, and commercial strategy from early planning through launch.
Our Services
Regulatory & Clinical Readiness
We help you align your clinical evidence, regulatory submissions, and documentation to U.S. expectations- ensuring the pathway to FDA clearance and early pilot studies is efficient and credible.
Reimbursement & Market Access
From coding and coverage strategy to payer engagement, we design the value story that accelerates acceptance and reimbursement - the essential foundation for commercial success in the U.S.
Commercial Strategy & Partnerships
We identify early stakeholder relationships critical to longer range market penetration, including key partnership opportunities with established U.S. medtech players- building traction and momentum long before you scale.
Global Experience, U.S. Execution
Our team brings decades of cross-functional experience launching products across the U.S. healthcare ecosystem. From this vantage point, we’re uniquely positioned to guide global innovators through the complexity and challenge of bringing new technologies into the U.S. market.
We don’t just advise — we work shoulder-to-shoulder with founders and executives, turning strategy into action through every phase of entry, validation, and scale.
Let’s explore your U.S. market pathway…
If your company is preparing to enter the U.S. medtech or diagnostics market, we’d welcome a conversation!
Submit your name and email, or contact us directly to schedule an introductory discussion.
Jeff Sherman
jsherman@endpointpartnersinc.com
Managing Partner,
Endpoint Partners, Inc.